Need for Liver Evaluation in Polycystic Ovary Syndrome
July 2007
in “
Journal of Hepatology
”

TLDR Women with PCOS often have liver disease, so liver health checks are important for them.
In the 2007 study by Cerda et al., 41% of the 41 women with Polycystic Ovary Syndrome (PCOS) were found to have nonalcoholic fatty liver disease (NAFLD), and 7 of these patients also had elevated aminotransferase levels, indicating a potential progression to nonalcoholic steatohepatitis (NASH). The study highlights the high prevalence of NAFLD among women with PCOS and underscores the importance of evaluating liver health in these patients. Given the association between PCOS and metabolic syndrome—a risk factor for NAFLD—the paper recommends that liver disease assessment should be a standard part of the management for women with PCOS and metabolic syndrome.